73803-06-2

Upstream product

• 642-38-6 quebrachitol 
• 98-88-4 benzoyl chloride 
• 58769-21-4 1-D-O-Methyl-chiro-inositol 

Downstream Products

• 73803-07-3 L-1,3,4,5,6-penta-O-benzoyl-chiro-inositol 
• 73763-43-6 L-1,3,4,5,6-penta-O-benzoyl-2-O-formyl-chiro-inositol 
• 20770-56-3 D-1,2,3,5,6-penta-O-benzoyl-chiro-inositol 
• 73763-43-6 D-1,2,4,5,6-penta-O-benzoyl-3-O-formyl-chiro-inositol 
• 73803-09-5 L-1,3,4,5,6-penta-O-benzoyl-muco-inositol 
• 73803-08-4 L-1,3,4,5,6-penta-O-benzoyl-2-O-tosyl-chiro-inositol 
• 17230-47-6 (-)-Proto-quercitol-pentabenzoat 

Relevant academic research and scientific papers

Synthesis and theoretical study of azido and amino inositol derivatives from L-quebrachitol

Some azido and amino inositol derivatives were synthesised from L-quebrachitol. The reaction between the mesylated compound and sodium azide was studied experimentally. Ab initio quantum mechanical calculations were carried out for this process to better

Synthesis and Akt inhibitory properties of a 1D-3,4-dideoxyphosphatidylinositol ether lipid

1D-3,4-Dideoxyphosphatidylinositol ether lipid 2, a PI analog, was synthesized through a sequence of protection/deprotection protocols and two Barton deoxygenation reactions, starting from L-(-)-quebrachitol. DDPIEL is 18-fold more potent than its monodeoxy counterpart DPIEL in the inhibition of PI3-K. (C) 2000 Published by Elsevier Science Ltd.